These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

131 related articles for article (PubMed ID: 37314950)

  • 21. Reconstruction of an in vitro cornea and its use for drug permeation studies from different formulations containing pilocarpine hydrochloride.
    Tegtmeyer S; Papantoniou I; Müller-Goymann CC
    Eur J Pharm Biopharm; 2001 Mar; 51(2):119-25. PubMed ID: 11226818
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Human cornea construct HCC-an alternative for in vitro permeation studies? A comparison with human donor corneas.
    Reichl S; Döhring S; Bednarz J; Müller-Goymann CC
    Eur J Pharm Biopharm; 2005 Jul; 60(2):305-8. PubMed ID: 15939241
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Proniosome-derived niosomes for tacrolimus topical ocular delivery: in vitro cornea permeation, ocular irritation, and in vivo anti-allograft rejection.
    Li Q; Li Z; Zeng W; Ge S; Lu H; Wu C; Ge L; Liang D; Xu Y
    Eur J Pharm Sci; 2014 Oct; 62():115-23. PubMed ID: 24905830
    [TBL] [Abstract][Full Text] [Related]  

  • 24. [Esterase activity of human organotypic cornea construct (HCC) as in vitro model for permeation studies].
    Meyer L; Bednarz J; Müller-Goymann CC; Reichl S
    Ophthalmologe; 2005 Oct; 102(10):971-80. PubMed ID: 15785910
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Ex vivo models to evaluate the role of ocular melanin in trans-scleral drug delivery.
    Pescina S; Santi P; Ferrari G; Padula C; Cavallini P; Govoni P; Nicoli S
    Eur J Pharm Sci; 2012 Aug; 46(5):475-83. PubMed ID: 22484210
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Natamycin solid lipid nanoparticles - sustained ocular delivery system of higher corneal penetration against deep fungal keratitis: preparation and optimization.
    Khames A; Khaleel MA; El-Badawy MF; El-Nezhawy AOH
    Int J Nanomedicine; 2019; 14():2515-2531. PubMed ID: 31040672
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Optimization of β-cyclodextrin consolidated micellar dispersion for promoting the transcorneal permeation of a practically insoluble drug.
    Sayed S; Elsayed I; Ismail MM
    Int J Pharm; 2018 Oct; 549(1-2):249-260. PubMed ID: 30077759
    [TBL] [Abstract][Full Text] [Related]  

  • 28. An Overview of Advanced
    Van Meenen J; Ní Dhubhghaill S; Van den Bogerd B; Koppen C
    Tissue Eng Part B Rev; 2022 Jun; 28(3):506-516. PubMed ID: 33878935
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Theoretical corneal permeation model for ionizable drugs.
    Friedrich SW; Cheng YL; Saville BA
    J Ocul Pharmacol; 1993; 9(3):229-49. PubMed ID: 8228531
    [TBL] [Abstract][Full Text] [Related]  

  • 30. The use of a porcine organotypic cornea construct for permeation studies from formulations containing befunolol hydrochloride.
    Reichl S; Müller-Goymann CC
    Int J Pharm; 2003 Jan; 250(1):191-201. PubMed ID: 12480285
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Cytochrome P450 Activity in Ex Vivo Cornea Models and a Human Cornea Construct.
    Kölln C; Reichl S
    J Pharm Sci; 2016 Jul; 105(7):2204-12. PubMed ID: 27212636
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Critical appraisal of alternative irritation models: three decades of testing ophthalmic pharmaceuticals.
    Abdelkader H; Pierscionek B; Carew M; Wu Z; Alany RG
    Br Med Bull; 2015 Mar; 113(1):59-71. PubMed ID: 25686845
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Acyclovir-Loaded Nanoemulsions: Preparation, Characterization and Irritancy Studies for Ophthalmic Delivery.
    Mohammadi M; Elahimehr Z; Mahboobian MM
    Curr Eye Res; 2021 Nov; 46(11):1646-1652. PubMed ID: 33979552
    [No Abstract]   [Full Text] [Related]  

  • 34. Prevalidation of a human cornea construct as an alternative to animal corneas for in vitro drug absorption studies.
    Hahne M; Zorn-Kruppa M; Guzman G; Brandner JM; Haltner-Ukomado E; Wätzig H; Reichl S
    J Pharm Sci; 2012 Aug; 101(8):2976-88. PubMed ID: 22581751
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Effect of liposomal formulation of ascorbic acid on corneal permeability.
    Csorba A; Katona G; Budai-Szűcs M; Balogh-Weiser D; Fadda AM; Caddeo C; Takács ÁI; Mátyus P; Balogh GT; Nagy ZZ
    Sci Rep; 2023 Mar; 13(1):3448. PubMed ID: 36859418
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Liposomes containing bile salts as novel ocular delivery systems for tacrolimus (FK506): in vitro characterization and improved corneal permeation.
    Dai Y; Zhou R; Liu L; Lu Y; Qi J; Wu W
    Int J Nanomedicine; 2013; 8():1921-33. PubMed ID: 23690687
    [TBL] [Abstract][Full Text] [Related]  

  • 37. In vitro, ex vivo and in vivo characterization of PLGA nanoparticles loading pranoprofen for ocular administration.
    Cañadas C; Alvarado H; Calpena AC; Silva AM; Souto EB; García ML; Abrego G
    Int J Pharm; 2016 Sep; 511(2):719-27. PubMed ID: 27480398
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Hyalugel-integrated liposomes as a novel ocular nanosized delivery system of fluconazole with promising prolonged effect.
    Moustafa MA; Elnaggar YSR; El-Refaie WM; Abdallah OY
    Int J Pharm; 2017 Dec; 534(1-2):14-24. PubMed ID: 28987453
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Enhancing and sustaining the topical ocular delivery of fluconazole using chitosan solution and poloxamer/chitosan in situ forming gel.
    Gratieri T; Gelfuso GM; de Freitas O; Rocha EM; Lopez RF
    Eur J Pharm Biopharm; 2011 Oct; 79(2):320-7. PubMed ID: 21641994
    [TBL] [Abstract][Full Text] [Related]  

  • 40. In vitro transcorneal permeation of ketorolac from oil based ocular drops and ophthalmic ointment.
    Malhotra M; Majumdar DK
    Indian J Exp Biol; 1997 Dec; 35(12):1324-30. PubMed ID: 9567769
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.